Evidence map›Paper›PMID 31252087›Full record

ArticlePractical radiation oncology2019

Comparison of Motion-Insensitive T2-Weighted MRI Pulse Sequences for Visualization of the Prostatic Urethra During MR Simulation.

Kristen L Zakian, Andreas Wibmer, Hebert A Vargas, Eveline Alberts, Mo Kadbi, Borys Mychalczak, Marisa Kollmeier, Daniel Gorovets, Sean McBride, Margie Hunt and 2 more

Open access · greenAbstract read
In one paragraph

Article in Practical radiation oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Prostate Stereotactic Body Radiation Therapy: An Overview of Toxicity and Dose Response.International journal of radiation oncology, biology, physics · 2021
    Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Kristen L ZakianDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address: zakiank@mskcc.org.
Andreas WibmerDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Hebert A VargasDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Eveline AlbertsPhilips Healthcare, Best, Netherlands.
Mo KadbiPhilips Healthcare, Best, Netherlands.
Borys MychalczakDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Marisa KollmeierDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Daniel GorovetsDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Sean McBrideDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Margie HuntDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York.
Michael J ZelefskyDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Neelam TyagiDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York.
Memorial Sloan Kettering Cancer Center · USPhilips (Netherlands) · NL

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Elisa de Stanchina · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

purposeThe use of magnetic resonance imaging (MRI) for radiation therapy simulation is growing because of its ability to provide excellent delineation of target tissue and organs at risk. With the use of hypofractionated schemes in prostate cancer, urethral sparing is essential; however, visualization of the prostatic urethra can be challenging because of the presence of benign prostatic hyperplasia as well as respiratory motion artifacts. The goal of this study was to compare the utility of 2 motion-insensitive, T2-weighted MRI pulse sequences for urethra visualization in the setting of MRI-based simulation. METHODS AND MATERIALS: Twenty-two patients undergoing MRI simulation without Foley catheters were imaged on a 3 Tesla MRI scanner between October 2018 and January 2019. Sagittal multislice data were acquired using (1) MultiVane XD radial sampling with parallel imaging acceleration (MVXD) and (2) single-shot fast-spin-echo (SSFSE) sequences with acquisition times of 2 to 3 minutes per sequence. For each examination, 2 genitourinary radiologists scored prostatic urethra visibility on a 1-to-5 scale and rated the signal-to-noise ratio and the presence of artifacts in each series.

resultsUrethral visibility was scored higher in the MVXD series than in the SSFSE series in 18 of 22 cases (Reader 1) and 17 of 22 cases (Reader 2). The differences in scores between MVXD and SSFSE were statistically significant for both readers (P < .0001 for both, paired Student's t-test) and interobserver agreement was high (Cohen's kappa = 0.67). Both readers found the signal-to-noise ratio of the MVXD sequence to be superior in all cases. The MVXD sequence was found to generate more artifacts than the SSFSE sequence, but these tended to appear in the periphery and did not affect the ability to visualize the urethra.

conclusionsA radial T2-weighted multislice pulse sequence was superior to an SSFSE sequence for visualization of the urethra in the setting of magnetic resonance simulation for prostate cancer.

Indexed as

HumansMagnetic Resonance ImagingMaleProstateProstatic NeoplasmsUrethra

Identifiers

PMID31252087
PMCPMC6832802
OpenAlexW2953644341

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.